Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
This study has been completed.
Study NCT00690807   Information provided by Provectus Pharmaceuticals
First Received: June 3, 2008   Last Updated: September 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atopic Dermatitis
Additional conditions recognized in this trial
Dermatitis
Dermatitis, Atopic
More general conditions related to this trial
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic
Interventions listed in this trial
PH-10
Sponsors listed in this trial
Provectus Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services